0001144204-18-008825.txt : 20180214 0001144204-18-008825.hdr.sgml : 20180214 20180214153314 ACCESSION NUMBER: 0001144204-18-008825 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 GROUP MEMBERS: ATV ASSOCIATES VIII, L.L.C. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88910 FILM NUMBER: 18611798 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Technology Ventures VIII LP CENTRAL INDEX KEY: 0001407426 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1000 Winter Str CITY: Waltham STATE: MA ZIP: 02451 BUSINESS PHONE: 781-290-0707 MAIL ADDRESS: STREET 1: 1000 Winter Str CITY: Waltham STATE: MA ZIP: 02451 SC 13G/A 1 tv485651_sc13ga.htm SC 13G/A

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1 )*

 

 

 

Catabasis Pharmaceuticals, Inc.

(Name of Issuer)

 

Common Stock, $0.001 par value

(Title of Class of Securities)

 

14875P107

(CUSIP Number)

 

December 31, 2017

(Date of Event Which Requires Filing of This Statement)

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

¨ Rule 13d-1(c)

 

x Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 14875P107   Page 2 of 9

             
  1.   

Name of Reporting Persons

 

Advanced Technology Ventures VIII, L.P.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  x1        (b)  ¨

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

   5.   

Sole Voting Power

 

0

  6.  

Shared Voting Power

 

1,133,9432

  7.  

Sole Dispositive Power

 

0

  8.  

Shared Dispositive Power

 

1,133,9432

   9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,133,9432

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.  

Percent of Class Represented by Amount in Row (9)

 

4.9%3

12.  

Type of Reporting Person (See Instructions)

 

PN

 

1 This Schedule 13G is being filed by Advanced Technology Ventures VIII, L.P. (“ATV VIII”) and ATV Associates VIII, L.L.C. (“ATVA VIII”), the general partner of ATV VIII.
   
2 Consists of shares held directly by ATV VIII.
   
3 This percentage is calculated based upon 23,083,177 shares of the Issuer’s common stock outstanding as of October 31, 2017, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2017.

 

 

 

 

CUSIP No. 14875P107   Page 3 of 9

             
  1.   

Name of Reporting Persons

 

ATV Associates VIII, L.L.C.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  x1        (b)  ¨

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

   5.   

Sole Voting Power

 

0

  6.  

Shared Voting Power

 

1,133,9432

  7.  

Sole Dispositive Power

 

0

  8.  

Shared Dispositive Power

 

1,133,9432

   9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,133,9432

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨

 

11.  

Percent of Class Represented by Amount in Row (9)

 

4.9%3

12.  

Type of Reporting Person (See Instructions)

 

OO

 

1 This Schedule 13G is being filed by Advanced Technology Ventures VIII, L.P. (“ATV VIII”) and ATV Associates VIII, L.L.C. (“ATVA VIII”), the general partner of ATV VIII.
   
2 Consists of shares held directly by ATV VIII.
   
3 This percentage is calculated based upon 23,083,177 shares of the Issuer’s common stock outstanding as of October 31, 2017, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2017.

 

 

 

 

CUSIP No. 14875P107   Page 4 of 9

 

Introductory Note: This Statement on Schedule 13G is filed on behalf of Advanced Technology Ventures VIII, L.P., a Delaware limited partnership (“ATV VIII”) and ATV Associates VIII, L.L.C., a Delaware limited liability company (“ATVA VIII”) in respect of shares of common stock of Catabasis Pharmaceuticals, Inc.

 

Item 1.

 

(a)Name of Issuer

 

Catabasis Pharmaceuticals, Inc.

  

  (b) Address of Issuer’s Principal Executive Offices

 

One Kendall Square

Bldg. 1400E, Suite B14202

Cambridge, MA 02139

 

Item 2.

 

  (a) Name of Person Filing

 

Advanced Technology Ventures VIII, L.P.

ATV Associates VIII, L.L.C.

 

  (b) Address of Principal Business Office or, if none, Residence

 

500 Boylston Street, Suite 1380, Boston, MA 02116

 

  (c) Citizenship

 

Both of the entities are organized under the laws of Delaware.

 

  (d) Title of Class of Securities

 

Common Stock, $0.001 par value

 

  (e) CUSIP Number

 

14875P107

 

Item 3.If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

 

Not applicable

 

 

 

 

CUSIP No. 14875P107   Page 5 of 9

 

Item 4.Ownership

 

(a)Amount Beneficially Owned as of December 31, 2017:

 

Advanced Technology Ventures VIII, L.P. 1,133,943 (1)
ATV Associates VIII, L.L.C. 1,133,943 (1)

 

  (b) Percent of Class as of December 31, 2017:

 

Advanced Technology Ventures VIII, L.P. 4.9%
ATV Associates VIII, L.L.C. 4.9%

 

  (c) Number of shares as to which the person has, as of December 31, 2017:

 

  (i) Sole power to vote or to direct the vote

 

Advanced Technology Ventures VIII, L.P. 0
ATV Associates VIII, L.L.C. 0

 

  (ii) Shared power to vote or to direct the vote

 

Advanced Technology Ventures VIII, L.P. 1,133,943 (1)
ATV Associates VIII, L.L.C. 1,133,943 (1)

 

  (v) Sole power to dispose or to direct the disposition of

 

Advanced Technology Ventures VIII, L.P. 0
ATV Associates VIII, L.L.C. 0

 

  (iv) Shared power to dispose or to direct the disposition of

 

Advanced Technology Ventures VIII, L.P. 1,133,943 (1)
ATV Associates VIII, L.L.C. 1,133,943 (1)

 

 

(1)These shares are owned directly by ATV VIII.

 

Item 5.Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. x

 

Item 6.Ownership of More than Five Percent on Behalf of Another Person

 

Not Applicable

 

 

 

 

CUSIP No. 14875P107   Page 6 of 9

 

Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

 

Not Applicable

 

Item 8.Identification and Classification of Members of the Group

 

Not Applicable

 

Item 9.Notice of Dissolution of a Group

 

Not Applicable

 

Item 10.Certification

 

Not Applicable

 

 

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

 

Dated: February 14, 2018

 

ADVANCED TECHNOLOGY VENTURES VIII, L.P.  
By:   ATV Associates VIII, L.L.C.  
     
By: /s/ Jean George  
Name: Jean George  
Title: Managing Director  
     
ATV ASSOCIATES VIII, L.L.C.  
     
By: /s/ Jean George  
Name: Jean George  
Title: Managing Director  

 

 

 

 

 

 

EXHIBITS

 

A:Joint Filing Agreement

 

 

 

 

 

 

EXHIBIT A

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Catabasis Pharmaceuticals, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

 

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 14th day of February, 2018.

 

ADVANCED TECHNOLOGY VENTURES VIII, L.P.  
By: ATV Associates VIII, L.L.C.  
     
By: /s/ Jean George  
Name: Jean George  
Title: Managing Director  
     
ATV ASSOCIATES VIII, L.L.C.  
     
By: /s/ Jean George  
Name: Jean George  
Title: Managing Director